Abstract: A dual-opening panoramic sunroof may include front glass which slides forward and rearward by being connected with a front sled that is slidable forward and rearward along a mechanism rail, a rear glass which slides forward and rearward by being connected with a rear sled, a front timing plate which has a rear end rotatably coupled to the rear sled, and a front end formed with a front groove to accommodate a portion of the front sled, and selectively connects the front sled and the rear sled, a rear tilt lever which is disposed rearward of the mechanism rail, and a rear timing plate which has a rear end rotatably coupled to the rear tilt sled, and a front end formed with a rear groove formed to selectively accommodate a portion of the rear sled, and connects the rear sled and the rear tilt sled.

Abstract: Methods for producing stabilized solid dosage form pharmaceutical compositions are provided. In particular, methods for preparing protected granules containing morphinans, and solid dosage form pharmaceutical compositions produced using the morphinan-protected granules are provided.

Abstract: An organic optoelectric device including an anode and a cathode facing each other, an emission layer between the anode and the cathode, a hole transport layer between the anode and the emission layer, a hole transport auxiliary layer between the hole transport layer and the emission layer, an electron transport layer between the cathode and the emission layer, and an electron transport auxiliary layer between the electron transport layer and the emission layer, wherein the electron transport auxiliary layer includes a first compound represented by the following Chemical Formula 1, and the hole transport auxiliary layer includes a second compound represented by the following Chemical Formula 2:

Abstract: The present disclosure provides an immediate release, abuse deterrent pharmaceutical solid dosage form comprising at least one functional score. In particular, the immediate release, abuse deterrent solid dosage form comprises at least one low molecular weight hydrophilic polymer, at least one high molecular weight hydrophilic polymer, and an effervescent system.

Abstract: A structure of a roll blind that moves in a front-back direction of a vehicle to selectively shade a sunroof glass may include a pair of sunroof frames formed on both lower sides of the sunroof glass in a longitudinal direction of the vehicle, a main roller disposed at the one end of the sunroof frame in a vehicle width direction and can rotate through a motor, an idle roller disposed in the vehicle width direction adjacent to the main roller, a roller tube coupled to and wrapping the main roller and the idle roller to form a closed loop, and a roller guide coupled to both ends of the main roller and the idle roller and including a guide portion formed to protrude so that the blind maintains a constant height.

Abstract: Methods for producing stabilized solid dosage form pharmaceutical compositions are provided. In particular, methods for preparing protected granules containing morphinans, and solid dosage form pharmaceutical compositions produced using the morphinan-protected granules are provided.

Abstract: A semiconductor device includes a nonvolatile memory storing encrypted management data, and a memory controller coupled between the nonvolatile memory and a host. The memory controller is allocated a free area in a host memory from the host and is suitable for storing the encrypted management data in the free area.

Abstract: A structure of a roll blind that moves in a front-back direction of a vehicle to selectively shade a sunroof glass may include a pair of sunroof frames formed on both lower sides of the sunroof glass in a longitudinal direction of the vehicle, a main roller disposed at the one end of the sunroof frame in a vehicle width direction and can rotate through a motor, an idle roller disposed in the vehicle width direction adjacent to the main roller, a roller tube coupled to and wrapping the main roller and the idle roller to form a closed loop, and a roller guide coupled to both ends of the main roller and the idle roller and including a guide portion formed to protrude so that the blind maintains a constant height.

Abstract: Methods for producing stabilized solid dosage form pharmaceutical compositions are provided. In particular, methods for preparing protected granules containing morphinans, and solid dosage form pharmaceutical compositions produced using the morphinan-protected granules are provided.

Abstract: The present disclosure provides an immediate release, abuse deterrent pharmaceutical solid dosage form comprising at least one functional score. In particular, the immediate release, abuse deterrent solid dosage form comprises at least one low molecular weight hydrophilic polymer, at least one high molecular weight hydrophilic polymer, and an effervescent system.

Abstract: Methods for producing stabilized solid dosage form pharmaceutical compositions are provided. In particular, methods for preparing protected granules containing morphinans, and solid dosage form pharmaceutical compositions produced using the morphinan-protected granules are provided.

Abstract: The present disclosure provides pharmaceutical compositions comprising at least one active pharmaceutical ingredient or a pharmaceutically acceptable salt thereof, at least one hydrophilic plastomer, optionally at least one hydrophilic elastomer, and at least one deliquescent plasticizer, wherein the pharmaceutical compositions provide extended release of the API and have abuse deterrent properties. Also provided are methods for preparing the pharmaceutical compositions in which the components of the composition are humidified such that the deliquescent plasticizer deliquesces, thereby plasticizing the hydrophilic polymers.

Abstract: Methods for producing stabilized solid dosage form pharmaceutical compositions are provided. In particular, methods for preparing protected granules containing morphinans, and solid dosage form pharmaceutical compositions produced using the morphinan-protected granules are provided.

Abstract: The present disclosure provides pharmaceutical compositions and processes for making solid dosage form pharmaceutical compositions that provide immediate release of active ingredients and have abuse deterrent properties. The pharmaceutical compositions provided herein comprise at least one pharmaceutically active ingredient, at least one low molecular weight hydrophilic polymer, at least one high molecular weight hydrophilic polymer, and an effervescent system.

Abstract: The present disclosure provides pharmaceutical compositions and processes for making solid dosage form pharmaceutical compositions that provide immediate release of active ingredients and have abuse deterrent properties. The pharmaceutical compositions provided herein comprise at least one pharmaceutically active ingredient, at least one low molecular weight water-soluble polymer, at least one polyglycol, at least one polysaccharide, at least one clay mineral, and, optionally, an effervescent system.

Abstract: Methods for producing stabilized solid dosage form pharmaceutical compositions are provided. In particular, methods for preparing protected granules containing morphinans, and solid dosage form pharmaceutical compositions produced using the morphinan-protected granules are provided.

Abstract: Provided herein is a method of manufacturing an organic electroluminescence display device, including the steps of: forming a getter layer on a unit sealing substrate using a dry method; providing a device substrate including a device array formed thereon, the device array including a plurality of unit organic electroluminescence devices; attaching the device substrate to the unit sealing substrate such that the getter layer faces the device array, thus forming a module; and imparting fluidity to the getter layer such that the getter layer covers upper and lateral sides of the device array. The method is advantageous in that fluidity is imparted to the getter layer, so that the upper and lateral sides of the device array is covered by the getter layer, thereby greatly improving the moisture resistance of the organic electroluminescence device.

Abstract: Methods for producing stabilized solid dosage form pharmaceutical compositions are provided. In particular, methods for preparing protected granules containing morphinans, and solid dosage form pharmaceutical compositions produced using the morphinan-protected granules are provided.

Abstract: Methods for producing stabilized solid dosage form pharmaceutical compositions are provided. In particular, methods for preparing protected granules containing morphinans, and solid dosage form pharmaceutical compositions produced using the morphinan-protected granules are provided.

Abstract: An apparatus for mounting a roof rack to a sunroof for a vehicle may include an outer sunroof frame covering at a first end thereof a sunroof actuating unit and being coupled at a second end thereof to a side outer panel, and/or a mounting member formed at the second end of the outer sunroof frame and coupled to the roof rack.